ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,302Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 1278

$619K Total Retail Price of All Prescriptions

Rank: 65 out of 1278

487 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,145 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 512 466 1 2
ATORVASTATIN CALCIUM 476 334 2 15
LISINOPRIL 410 328 3 1
OMEPRAZOLE 375 315 4 6
METFORMIN HCL 372 275 5 4
HYDROCODONE-ACETAMINOPHEN 270 216 S3 6 7
LOVASTATIN 240 187 7 13
WARFARIN SODIUM 205 162 8 17
PRAVASTATIN SODIUM 194 158 9 14
ZOLPIDEM TARTRATE 189 183 10 16
ATENOLOL 188 155 11 11
AMLODIPINE BESYLATE 173 167 12 5
SIMVASTATIN 170 152 13 3
POTASSIUM CHLORIDE 158 118 14 21
CARVEDILOL 143 127 15 39
MELOXICAM 143 104 15 57
FUROSEMIDE 142 119 17 10
GABAPENTIN 138 133 18 12
FLUTICASONE PROPIONATE 137 82 19 24
LOSARTAN POTASSIUM 135 117 20 19
ALENDRONATE SODIUM 130 93 21 18
CRESTOR 128 110 22 31
SPIRONOLACTONE 119 111 23 78
RANITIDINE HCL 113 56 24 20
METOPROLOL TARTRATE 110 86 25 9
KLOR-CON 10 102 85 26 91
ADVAIR DISKUS 90 63 27 49
TAMSULOSIN HCL 86 69 28 32
PAROXETINE HCL 79 55 29 56
CARISOPRODOL 77 41 R 30 51
MORPHINE SULFATE ER 76 27 S2 31 42
ZETIA 75 41 32 88
TRAMADOL HCL 74 68 33 25
CYCLOBENZAPRINE HCL 65 49 R 34 62
FENOFIBRATE 64 39 35 47
AZITHROMYCIN 64 57 35 37
TRAZODONE HCL 62 44 37 38
ESTRADIOL 62 49 R 37 71
OXYCODONE HCL 61 32 S2 39 27
FINASTERIDE 60 52 40 82
CLOPIDOGREL 60 57 40 45
TRIAMTERENE-HCTZ 59 58 42 43
METOPROLOL SUCCINATE 56 39 43 23
LIVALO 55 55 44 335
FELODIPINE ER 55 55 44 137
EVISTA 55 54 44 99
TRIAMCINOLONE ACETONIDE 53 41 47 110
DOXEPIN HCL 53 41 47 208
VERAPAMIL ER 52 50 49 84
ALLOPURINOL 52 39 49 36
LEVOXYL 52 44 49 94
PRADAXA 51 51 52 278
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.